# EDGAR Filing Document

**Accession Number:** 0001823758
**File Stem:** 0001178913-23-000318
**Filing Date:** 2023-1
**Character Count:** 7058
**Document Hash:** 462db2430a2821758fc4d4b97a9eb769
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001178913-23-000318.hdr.sgml**: 20230130

**ACCESSION NUMBER**: 0001178913-23-000318

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230119

**FILED AS OF DATE**: 20230130

**DATE AS OF CHANGE**: 20230130

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** aMoon Growth Fund Limited Partnership
- **CENTRAL INDEX KEY:** 0001744099
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36138
- **FILM NUMBER:** 23565148

**BUSINESS ADDRESS:**
- **STREET 1:** 34 YERUSHALAYIM RD.
- **CITY:** RAANANA
- **STATE:** L3
- **ZIP:** 4350110
- **BUSINESS PHONE:** 972(73)3989560

**MAIL ADDRESS:**
- **STREET 1:** 34 YERUSHALAYIM RD.
- **CITY:** RAANANA
- **STATE:** L3
- **ZIP:** 4350110

**FORMER NAME:**
- **FORMER CONFORMED NAME:** aMoon 2 Fund Limited Partnership
- **DATE OF NAME CHANGE:** 20180620
**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Schindel Yair Chaim
- **CENTRAL INDEX KEY:** 0001823758

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36138
- **FILM NUMBER:** 23565147

**MAIL ADDRESS:**
- **STREET 1:** YERUSHALAYIM ROAD 34
- **STREET 2:** BEIT GAMLA ENTRANCE B
- **CITY:** RA'ANANA
- **STATE:** L3
- **ZIP:** 4350110
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ayala Pharmaceuticals, Inc.
- **CENTRAL INDEX KEY:** 0001100397
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 841521955
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**BUSINESS ADDRESS:**
- **STREET 1:** 9 DEER PARK DRIVE
- **STREET 2:** SUITE K-1
- **CITY:** MONMOUTH JUNCTION
- **STATE:** NJ
- **ZIP:** 08852
- **BUSINESS PHONE:** 732 545 1590

**MAIL ADDRESS:**
- **STREET 1:** 9 DEER PARK DRIVE
- **STREET 2:** SUITE K-1
- **CITY:** MONMOUTH JUNCTION
- **STATE:** NJ
- **ZIP:** 08852

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Advaxis, Inc.
- **DATE OF NAME CHANGE:** 20050105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GREAT EXPECTATIONS & ASSOCIATES INC
- **DATE OF NAME CHANGE:** 19991203

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>aMoon Growth Fund Limited Partnership<br><sub>(Last) (First) (Middle)</sub><br>34 YERUSHALAIM ROAD<br>BEIT GAMLA, 6TH FLOOR<br><sub>(Street)</sub><br>RAANANA, L3 4350110<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Ayala Pharmaceuticals, Inc. [ ADXS ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-19 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Schindel Yair Chaim<br><sub>(Last) (First) (Middle)</sub><br>34 YERUSHALAIM ROAD<br>BEIT GAMLA, 6TH FLOOR<br><sub>(Street)</sub><br>RAANANA, L3 4350110<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Ayala Pharmaceuticals, Inc. [ ADXS ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-19 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [X] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[ ] Form filed by One Reporting Person<br>[X] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 560602 | D<sup>(1)</sup> |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The reported shares are held of record by aMoon Growth Fund, Limited Partnership ("aMoon Growth Fund"). aMoon Growth Fund G.P. Limited Partnership ("aMoon Growth Fund G.P.") is the sole General Partner of aMoon Growth Fund and aMoon General Partner Ltd. ("aMoon General Partner") is the sole General Partner of aMoon Growth Fund G.P. Dr. Yair Schindel is the sole shareholder of aMoon General Partner. By virtue of such relationships, aMoon Growth Fund G.P., aMoon General Partner and Dr. Schindel may be deemed to have shared voting and investment power with respect to the shares held of record by aMoon Growth Fund. Each of aMoon Growth Fund G.P., aMoon General Partner and Dr. Schindel disclaims beneficial ownership of the shares held by aMoon Growth Fund except to the extent of its or his pecuniary interest therein, if any.

**Signature:** /s/ Yair Schindel on behalf of himself and the sole shareholder of aMoon General Partner Ltd., the sole General Partner of aMoon Growth Fund G.P. Limited Partnership, the sole General Partner of aMoon Growth Fund, Limited Partnership  
**Date:** 2023-01-30

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**